Portfolio Company · Operating Co.

Ideem

Health-Tech · Website

backed byWavemaker 360 Health

CurrentHealth-Tech

Ideem

a portfolio company of

Wavemaker 360 Health

Status on record: Current

PE Firm Index

Who owns Ideem?

Ideem is listed as a current portfolio company of Wavemaker 360 Health on Wavemaker 360 Health's own portfolio page.

From the company's website

Ideem built Passkeys+, a composite authenticator with device binding at its core, and implements it end to end for banks and fintechs.

Source: useideem.com, read November 2026

Company Snapshot

Ideem is a Health-Tech company. Its owner on record, Wavemaker 360 Health, is a firm. Wavemaker 360 Health lists 62 companies in the index, 52 of them in Health-Tech.

SectorHealth-Tech

Parent PE firmWavemaker 360 Health

Ownership statusCurrent

WebsiteVisit ↗

About the owner

Wavemaker 360 Health

Companies in the index: 62

Healthcare-focused early-stage venture capital firm.

Read the Wavemaker 360 Health profile

Questions about Ideem

Who owns Ideem?

Ideem is listed as a current portfolio company of Wavemaker 360 Health on Wavemaker 360 Health's own portfolio page.

What sector is Ideem in?

Ideem is in Health-Tech. Classified from the owner's portfolio label.

What else does Wavemaker 360 Health own in Health-Tech?

Wavemaker 360 Health lists 51 other Health-Tech companies in the index, including 32co, Advocatia, Airpay, Alertive and Arcuity AI.

What is Ideem's website?

Ideem's website is https://www.useideem.com/.

Sources

Wavemaker 360 Health's page on Ideem
Wavemaker 360 Health
https://www.wavemaker360.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Ideem and does not provide investment advice.

Other portfolio companies of Wavemaker 360 Health

6 of 61 shown

See the full Wavemaker 360 Health portfolio.

Other Health-Tech companies held by Wavemaker 360 Health

32co Advocatia Airpay Alertive Arcuity AI Astromind

Other Health-Tech portfolio companies

3P Biopharmaceuticals

via Marlin Equity Partners

A-S Medication Solutions (ASMS)

via Warburg Pincus

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Wavemaker 360 Health

Status: Current

Check this company's website

Check this company's website now

Free, in about two minutes: the verified issues a buyer or a customer's browser would meet. Runs on GTM Brain, by DevriX.

Observational measurements of this company's public website only. Not a rating of the company, its performance, its management, or its investment merit. Not investment advice. Request a correction or removal via Submit Update.

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.